Daiichi Sankyo
Nipa Patel is an experienced professional in trial feasibility and site intelligence, currently serving as Associate Director at Daiichi Sankyo, Inc. since June 2021. Prior to this role, Nipa held various positions at ICON plc from June 2012 to May 2021, including Site Identification Manager and Senior Feasibility and Site Specialist. Nipa's career began at inVentiv Health Clinical and IQVIA, where roles included Feasibility Associates and Associate Feasibility Specialist. Initial industry experience was gained at PPD as a Medical Communication Specialist and at Catalent Pharma Solutions as a Chemist. Nipa Patel earned a Bachelor of Science in Pharmaceutical Science from Campbell University between 2002 and 2005.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.